These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34927311)

  • 1. Thrombospondin-1 induced programmed death-ligand 1-mediated immunosuppression by activating the STAT3 pathway in osteosarcoma.
    Liu Z; Wen J; Hu F; Wang J; Hu C; Zhang W
    Cancer Sci; 2022 Feb; 113(2):432-445. PubMed ID: 34927311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Water extract of sporoderm-broken spores of Ganoderma lucidum enhanced pd-l1 antibody efficiency through downregulation and relieved complications of pd-l1 monoclonal antibody.
    He J; Zhang W; Di T; Meng J; Qi Y; Li G; Zhang Y; Su H; Yan W
    Biomed Pharmacother; 2020 Nov; 131():110541. PubMed ID: 33152901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LRP8 activates STAT3 to induce PD-L1 expression in osteosarcoma.
    Zheng S; Wei Y; Jiang Y; Hao Y
    Tumori; 2021 Jun; 107(3):238-246. PubMed ID: 33054597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-200a induces immunosuppression by promoting PTEN-mediated PD-L1 upregulation in osteosarcoma.
    Liu Z; Wen J; Wu C; Hu C; Wang J; Bao Q; Wang H; Wang J; Zhou Q; Wei L; Shen Y; Zhang W
    Aging (Albany NY); 2020 Jan; 12(2):1213-1236. PubMed ID: 31981455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomes loaded with programmed death ligand-1 promote tumor growth by immunosuppression in osteosarcoma.
    Zhang L; Xue L; Wu Y; Wu Q; Ren H; Song X
    Bioengineered; 2021 Dec; 12(2):9520-9530. PubMed ID: 34699324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Checkpoint Blockade in Combination With Doxorubicin Augments Tumor Cell Apoptosis in Osteosarcoma.
    Wang J; Hu C; Wang J; Shen Y; Bao Q; He F; Wang H; Gong L; Liu Z; Hu F; Liang J; Zhou Q; Wei L; Wen J; Zhang W
    J Immunother; 2019; 42(9):321-330. PubMed ID: 31219973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apatinib inhibits migration and invasion as well as PD-L1 expression in osteosarcoma by targeting STAT3.
    Zheng B; Ren T; Huang Y; Guo W
    Biochem Biophys Res Commun; 2018 Jan; 495(2):1695-1701. PubMed ID: 29225166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 9. Sunitinib inhibits PD-L1 expression in osteosarcoma by targeting STAT3 and remodels the immune system in tumor-bearing mice.
    Duan XL; Guo JP; Li F; Xiu C; Wang H
    Future Oncol; 2020 Aug; 16(24):1815-1824. PubMed ID: 32511016
    [No Abstract]   [Full Text] [Related]  

  • 10. PD-L1 and IDO1 expression and tumor-infiltrating lymphocytes in osteosarcoma patients: comparative study of primary and metastatic lesions.
    Toda Y; Kohashi K; Yamada Y; Yoshimoto M; Ishihara S; Ito Y; Iwasaki T; Yamamoto H; Matsumoto Y; Nakashima Y; Mawatari M; Oda Y
    J Cancer Res Clin Oncol; 2020 Oct; 146(10):2607-2620. PubMed ID: 32388585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the HDAC6/STAT3 pathway in regulating PD-L1 expression in osteosarcoma cell lines.
    Keremu A; Aimaiti A; Liang Z; Zou X
    Cancer Chemother Pharmacol; 2019 Feb; 83(2):255-264. PubMed ID: 30430228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced T-cell immunity to osteosarcoma through antibody blockade of PD-1/PD-L1 interactions.
    Lussier DM; O'Neill L; Nieves LM; McAfee MS; Holechek SA; Collins AW; Dickman P; Jacobsen J; Hingorani P; Blattman JN
    J Immunother; 2015 Apr; 38(3):96-106. PubMed ID: 25751499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progranulin induces immune escape in breast cancer via up-regulating PD-L1 expression on tumor-associated macrophages (TAMs) and promoting CD8
    Fang W; Zhou T; Shi H; Yao M; Zhang D; Qian H; Zeng Q; Wang Y; Jin F; Chai C; Chen T
    J Exp Clin Cancer Res; 2021 Jan; 40(1):4. PubMed ID: 33390170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sorafenib inhibits doxorubicin-induced PD-L1 upregulation to improve immunosuppressive microenvironment in Osteosarcoma.
    Wang J; Hu F; Yu P; Wang J; Liu Z; Bao Q; Zhang W; Wen J
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):5127-5138. PubMed ID: 36348018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PRG4 represses the genesis and metastasis of osteosarcoma by inhibiting PDL1 expression.
    Zhang L; Ren H; Wu Y; Xue L; Bai Y; Wei D; Wu Q
    Tissue Cell; 2024 Jun; 88():102409. PubMed ID: 38781792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High baseline tumor burden-associated macrophages promote an immunosuppressive microenvironment and reduce the efficacy of immune checkpoint inhibitors through the IGFBP2-STAT3-PD-L1 pathway.
    Wen Z; Sun H; Zhang Z; Zheng Y; Zheng S; Bin J; Liao Y; Shi M; Zhou R; Liao W
    Cancer Commun (Lond); 2023 May; 43(5):562-581. PubMed ID: 37031362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FGFR2 Promotes Expression of PD-L1 in Colorectal Cancer via the JAK/STAT3 Signaling Pathway.
    Li P; Huang T; Zou Q; Liu D; Wang Y; Tan X; Wei Y; Qiu H
    J Immunol; 2019 May; 202(10):3065-3075. PubMed ID: 30979816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
    Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
    Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceleration of pancreatic tumorigenesis under immunosuppressive microenvironment induced by Reg3g overexpression.
    Liu X; Zhou Z; Cheng Q; Wang H; Cao H; Xu Q; Tuo Y; Jiang L; Zou Y; Ren H; Xiang M
    Cell Death Dis; 2017 Sep; 8(9):e3033. PubMed ID: 28880262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-4458 Regulates PD-L1 Expression to Enhance Anti-tumor Immunity in NSCLC via Targeting STAT3.
    Liu W; Liu R; Yuan R; Wang X
    Mol Biotechnol; 2021 Dec; 63(12):1268-1279. PubMed ID: 34386930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.